Hutch News

Hutch News

Stories tagged 'cord blood stem cells'

‘I want this to be something everyone can get’

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein

Dec. 3, 2015 | By Susan Keown / Fred Hutch News Service

A new Fred Hutch spinoff, Nohla Therapeutics, will commercialize cord blood stem cell therapies based on work by Dr. Colleen Delaney and Dr. Irwin Bernstein. In preliminary studies, the company’s first product helps stem cells engraft more quickly after transplant and protects patients from deadly infections during this vulnerable period.

View story >

'A chance to hope': Leukemia survivor, family reunite with favorite doctor

Ex-patient’s wife recalls how her sacred mission to save her husband led her to Fred Hutch

Aug. 26, 2015 | By Bill Briggs / Fred Hutch News Service

After her husband, Hugh, was diagnosed with an aggressive form of leukemia, Aimee Fagan filled a notebook with doctors' names, study results, and this mantra: 'It's you and me against cancer, do you think it has a chance?'

View story >

‘It made me more grateful’

An extraordinary girl contends with a rare, life-threatening blood disease — and undergoes a made-to-order clinical study in cord-blood transplantation

Jan. 5, 2015 | By Ellie Sheldon / Seattle Cancer Care Alliance

Since being diagnosed with aplastic anemia in 2009, Kyra Diaz, 11, has stood tall through a series of demanding medical treatments to arrest and, finally, cure her disease. Ultimately, in October 2013, she received a transplant of stem cells derived from umbilical cord blood developed by researchers at Fred Hutchinson Cancer Research Center that saved her life.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.